These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 32169519)
1. Potential sphingosine-1-phosphate-related therapeutic targets in the treatment of cerebral ischemia reperfusion injury. Han M; Sun T; Chen H; Han M; Wang D Life Sci; 2020 May; 249():117542. PubMed ID: 32169519 [TBL] [Abstract][Full Text] [Related]
2. Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke. Salas-Perdomo A; Miró-Mur F; Gallizioli M; Brait VH; Justicia C; Meissner A; Urra X; Chamorro A; Planas AM Sci Rep; 2019 Jun; 9(1):8309. PubMed ID: 31165772 [TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia-Triggered Sphingosine-1-Phosphate and Sphingosine-1-Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization. Hu Y; Yang C; Shen G; Yang S; Cheng X; Cheng F; Rao J; Wang X Liver Transpl; 2019 Jul; 25(7):1074-1090. PubMed ID: 30972941 [TBL] [Abstract][Full Text] [Related]
9. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning. Vessey DA; Li L; Imhof I; Honbo N; Karliner JS Med Sci Monit Basic Res; 2013 Apr; 19():126-32. PubMed ID: 23567658 [TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate signaling in ischemia and reperfusion injury. Raza Z; Saleem U; Naureen Z Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106436. PubMed ID: 32173486 [TBL] [Abstract][Full Text] [Related]
11. Selective Sphingosine 1-Phosphate Receptor 1 Agonist Is Protective Against Ischemia/Reperfusion in Mice. Brait VH; Tarrasón G; Gavaldà A; Godessart N; Planas AM Stroke; 2016 Dec; 47(12):3053-3056. PubMed ID: 27827329 [TBL] [Abstract][Full Text] [Related]
12. Updates on sphingolipids: Spotlight on retinopathy. Shiwani HA; Elfaki MY; Memon D; Ali S; Aziz A; Egom EE Biomed Pharmacother; 2021 Nov; 143():112197. PubMed ID: 34560541 [TBL] [Abstract][Full Text] [Related]
13. The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment. Leo A; Citraro R; Marra R; Palma E; Paola EDD; Constanti A; De Sarro G; Russo E CNS Neurol Disord Drug Targets; 2017; 16(3):311-325. PubMed ID: 27823573 [TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation. Tsai HC; Han MH Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702 [TBL] [Abstract][Full Text] [Related]
15. Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment. Chua XY; Ho LTY; Xiang P; Chew WS; Lam BWS; Chen CP; Ong WY; Lai MKP; Herr DR Neuromolecular Med; 2021 Mar; 23(1):47-67. PubMed ID: 33180310 [TBL] [Abstract][Full Text] [Related]
16. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia. Serdar M; Herz J; Kempe K; Lumpe K; Reinboth BS; Sizonenko SV; Hou X; Herrmann R; Hadamitzky M; Heumann R; Hansen W; Sifringer M; van de Looij Y; Felderhoff-Müser U; Bendix I Brain Behav Immun; 2016 Feb; 52():106-119. PubMed ID: 26456693 [TBL] [Abstract][Full Text] [Related]
17. Fingolimod attenuates renal ischemia/reperfusion-induced acute lung injury by inhibiting inflammation and apoptosis and modulating S1P metabolism. Shi ZA; Li TT; Kang DL; Su H; Tu FP J Int Med Res; 2021 Aug; 49(8):3000605211032806. PubMed ID: 34340580 [TBL] [Abstract][Full Text] [Related]